Test Code COVS2 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Spike Antibody, Semi-Quantitative, Serum
Reporting Name
SARS-CoV-2 Spike Ab, Semi-Quant, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Aiding in the identification of individuals with an adaptive immune response to SARS-CoV-2, indicating prior infection or vaccination
Manufacture of COVID-19 convalescent plasma
Ordering Guidance
For confirmation of prior infection in the presence of vaccination, order COVTA / Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), Nucleocapsid, Total Antibody, Serum.
Molecular testing is recommended for diagnosis of COVID-19 in symptomatic patients. For more information see COVOO / Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA Detection, Varies.
For the most up-to-date coronavirus disease 2019 (COVID-19) epidemiology and testing recommendations, visit www.cdc.gov/coronavirus/2019-ncov/index.html.
Necessary Information
1. Patient's race and ethnicity, as well as collection date, are required.
2. If ordering electronically, answers must be provided for the order entry questions.
3. If not ordering electronically, patient race and ethnicity must be provided on the request form.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial
Specimen Minimum Volume
0.75 mL
Specimen Type
SerumSpecimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Day(s) Performed
Monday through Saturday
Report Available
1 to 3 daysMethod Name
Electrochemiluminescence Immunoassay (ECLIA)
Test Classification
This test has received Emergency Use Authorization (EUA) by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86769
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
COVSQ | SARS-CoV-2 Spike Ab, Semi-Quant, S | 94769-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
COVIN | SARS-CoV-2 Spike Ab, Interp, S | 94661-6 |
COVQN | SARS-CoV-2 Spike Ab, Quant, S | 94769-7 |
SRACE | Patient's Race | 72826-1 |
SETHN | Patient's Ethnicity | 69490-1 |